Combination therapy with cyclosporine and interleukin-4 or interleukin- 10 prolongs survival of syngeneic pancreatic islet grafts in nonobese diabetic mice: Islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-β in the islet grafts

Transplantation

Volumn 64, Issue 11, 1997, Pages 1525-1531

  Rabinovitch, Alex ^a   Suarez Pinzon, Wilma L ^a   Sorensen, Ole ^a   Rajotte, Ray V ^a   Power, Robert F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; GRAFT SURVIVAL; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; CYCLOSPORINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; INTERLEUKIN-4; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED NOD; RNA, MESSENGER;

EID: 0031443261     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712150-00004     Document Type: Article

References (20)

1. Sibley RK, Sutherland DER, Goetz F, Michael AF. Recurrent diabetes mellitus in the pancreas iso- and allograft. Lab Invest 1985; 53: 132.
2. Crisa L, Mordes JP, Rossini AA. Autoimmune diabetes in the BB rat. Diabetes Metab Rev 1992; 8: 9.
3. Kikutani H, Makino S. The murine autoimmune diabetes model: NOD mouse and related strains. In: Dixon FJ, ed. Advances in immunology. New York: Academic Press, 1992: 285.
4. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 1994; 43: 613.
5. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16: 34.
6. Hancock WW, Polanski M, Zhang J, Blogg N, Weiner HL. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin E. Am J Pathol 1995; 147: 1193.
7. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF, Rajotte RV. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Transplantation 1995; 60: 368.
8. Faust A, Rothe H, Schade U, Lampeter E, Kolb H. Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10. Transplantation 1996; 62: 648.
9. Zheng XX, Strom TB, Steele AW. Quantitative comparison of rapamycin and cyclosporine effects on cytokine gene expression studied by reverse transcriptase-competitive polymerase chain reaction. Transplantation 1994; 58: 87.
10. Wang T, Singh B, Warnock GL, Rajotte RV. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 1992; 41: 114.
11. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter KT. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294.
12. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol 1994; 154: 4874.
13. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992; 149: 2496.
14. Campbell IL, Kay TWH, Oxbrow L, Harrison LC. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 1991; 87: 739.
15. Shehadeh N, LaRosa F, Lafferty KJ. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 1993; 6: 291.
16. Rothe H, Faust A, Schade U, et al. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-γ, but not of interleukin-4. Diabetologia 1994; 37: 1154.
17. Rabinovitch A, Sorensen O, Suarez-Pinzon WL, Power RF, Rajotte RV, Bleackley RC. Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and interferon gamma mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia 1994; 37: 833.
18. Muir A, Peck A, Clare-Salzler M, et al. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J Clin Invest 1995; 95: 628.
19. Trembleau S, Penna G, Gregori S, Magram T, Gately MK, Adorini L. The role of endogenous IL-12 in the development of spontaneous diabetes in NOD mice. Autoimmunity 1995; 21: 23.
20. Rothe H, Burkart V, Faust A, Kolb H. Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice. Diabetologia 1996; 39: 119.